ANI Pharmaceuticals Schedules Conference Call to Discuss Third Quarter 2020 Financial Results
October 29 2020 - 6:50AM
Business Wire
ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ:
ANIP) today announced that the Company will release its third
quarter 2020 financial results on Thursday, November 5, 2020,
before the opening of the U.S. financial markets.
Nikhil Lalwani, President and Chief Executive Officer, and
Stephen P. Carey, Vice President, Finance, and Chief Financial
Officer, will host a conference call to discuss the results as
follows:
Date
Thursday, November 5, 2020
Time
10:30 a.m. ET
Toll free (U.S.)
(866) 776-8875
Webcast (live and replay)
www.anipharmaceuticals.com, under the
“Investors” section
A replay of the conference call will be available within two
hours of the call’s completion and will remain accessible for
one-week by dialing (800) 585-8367 and entering access code
7454258.
About ANI
ANI Pharmaceuticals, Inc. is an integrated specialty
pharmaceutical company focused on delivering value to our customers
by developing, manufacturing, and marketing high quality branded
and generic prescription pharmaceuticals. The Company's targeted
areas of product development currently include controlled
substances, oncolytics (anti-cancers), hormones and steroids, and
complex formulations involving extended release and combination
products. For more information, please visit our website
www.anipharmaceuticals.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201029005400/en/
Investor Relations: Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793 E: lwilson@insitecony.com
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Apr 2024 to May 2024
ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From May 2023 to May 2024